Terms ending in 2037
Every in-force patent on Universitat Basel's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,484,572 | Use of HLA-B27 Homodimers for Cancer Treatment In force · High confidence | Universitat Zurich | In force | High confidence | |
| US 11,369,660 | Method of Treating Cancer with an HLA-B57 Open Conformer In force · High confidence | Universitat Basel | In force | High confidence | |
| US 12,144,299 | Mobilisation of Transposable Elements to Enhance Genetic and Epigenetic Variability in a Population In force · High confidence | Universitat Basel | In force | High confidence | |
| US 11,807,676 | MHC Class Ia Open Conformers In force · High confidence | Universität Basel | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Universitat Basel.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.